Xingwei Wang

Cost-effectiveness analysis of pembrolizumab plus standard chemotherapy versus chemotherapy alone for first-line treatment of metastatic non-squamous non–small-cell lung cancer in China

Yuan Jiang, Xingwei Wang, 2020, European journal of hospital pharmacy : science and practice.

KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer

X. Hong, Yan Ding, Chen Chen, 2022, Journal of oncology.

Application of Circular RNA Circ_0071662 in the Diagnosis and Prognosis of Hepatocellular Carcinoma and Its Response to Radiotherapy

Jing Zhang, Fang Luo, Xingwei Wang, 2022, Digestive Diseases.